Destiny Pharma CEO, Neil Clark, to present at the HC Wainwright 24th Annual Global Investment Conference

Wednesday September 7, 2022

Destiny Pharma CEO, Neil Clark, to present at the HC Wainwright 24th Annual Global Investment Conference

Destiny Pharma plc (AIM:DEST), a clinical stage biotechnology company focused on the development of novel medicines to prevent life threatening infections, today announces that Destiny Pharma’s CEO, Neil Clark, will present virtually at the upcoming HC Wainwright 24th Annual Global Investment Conference, being held on 12-14 September 2022 in New York and virtually.

The presentation will be available to view on demand from 1200 BST / 0700 ET on Monday 12 September 2022.  To join the conference virtually, view the presentation and ask any questions, please click on the link above to register.

Presentation Title:      Destiny Pharma Company Presentation

Presenter:                     Neil Clark

If you would like to meet with Destiny Pharma, please email us at or contact us through the HC Wainwright conference meeting system if you are registered.